Dennis Partners

Dennis Partners

A Leader in Regulatory Affairs Recruiting

A Leader in Regulatory Affairs Recruiting

Mission: Our goal at Dennis Partners is to become the premier Regulatory Affairs recruiting specialist for both our clients and our candidates.

See you in 2019!

indeed.com

Sales Development Associate - Cape Cod, MA - Indeed.com

Did you know that we're hiring??
This role is for someone who loves to learn and welcomes any opportunity to meet someone new 👇👇👇

indeed.com Over the past 15 years, we have seen the Regulatory Affairs community evolve based upon the globalization of market demands. At Dennis Partners, we exclusively specialize in the placement of professionals from mid-level management through Executive leadership.

Hey friends, we're doing some internal hiring here for two different sales roles. Check them out 👇👇

Sales Development Associate
https://www.indeed.com/cmp/Dennis-Partners/jobs/Sales-Development-Associate-ce6d68395a9d28ae

Executive Search Consultant
https://www.indeed.com/cmp/Dennis-Partners/jobs/Executive-Search-Consultant-00c3e9a2658d7057
#MustLoveDogs

"Don't hang up on me; I'm not a bill collector!"
#DPDogs

ANNOUNCEMENT:
Dennis Partners will be closed for Labor Day Weekend starting Friday 8/31. Feel free to email/call but please be patient as there may be a slight delay in response. We will be back in the office on Tuesday 9/4
#LaborDayWeekend

When you become best friends with your work colleague #DPDogs

raps.org

Regulatory Explainer: Everything You Need to Know About FDA’s Priority Review Vouchers

Find out in our latest Regulatory Explainer on the Priority Review Voucher system.
#RegulatoryAffairs #PriorityReview #DrugApprovals
http://ow.ly/x6uc30l5fMn

raps.org Since 2007, the US Food and Drug Administration (FDA) has issued a handful of special "priority review" vouchers which allow its recipient to expedite the review of any one of its new drug products. What are these vouchers, why is FDA issuing them and what benefit might they have for society? Find o...

hrdive.com

Counteroffers don't get employees to stay, after all

"Of the 5,500 hiring decision-makers polled, 58% said they extend counteroffers to departing employees. Senior managers said they saw employees stay an average of 1.7 years after giving them a counteroffer."
#CounterOffer #Hiring
http://ow.ly/K8Ze30l1JgJ

hrdive.com Employers must understand why an employee may be leaving and seek to solve the underlying issues rather than shell out money as a stopgap.

Perfect day for minigolf!

biopharmadive.com

FDA seeking 'right balance' in regulating opioid prescriptions

"The roots of this crisis are embedded in the practice of medicine, and prescribing practices that were at times too cavalier," Gottlieb said.
#Opioid #DrugApproval
http://ow.ly/LGXm30kUj7f

biopharmadive.com Despite some progress made, the agency chief called for further reductions in the number of prescriptions written for opioids. 

drugtopics.com

International Group Pushes for 9 New Drug Labeling, Packaging Guidelines | Drug Topics

International Group Pushes for 9 New Drug Labeling, Packaging Guidelines
#RegulatoryAffairs #Packaging #Labeling
http://ow.ly/Xiir30kMRe2

drugtopics.com Standardization coming for drug labeling and packaging.

Our office will be closed today to celebrate our nation's independence but we're back in on Thursday!

drugs.com

Scientists Spot Gene Linking Down Syndrome, Early Alzheimer's

Scientists Spot Gene Linking Down Syndrome, Early Alzheimer's
#DownsSyndrome #Alzheimers http://ow.ly/kNfQ30kMyof

drugs.com British researchers are zeroing in on the genes that they believe are responsible for early onset Alzheimer's disease in people with Down syndrome.

We've got a big #DPDogs squad today!

linkedin.com

Recruiter VS Applying Directly

Why go it alone?
#Hiring #RegulatoryAffairs
https://www.linkedin.com/pulse/recruiter-vs-applying-directly-edward-canning-csam

linkedin.com In my daily conversations with candidates, a recurring topic is whether they should utilize the services of a professional recruiter or apply directly

linkedin.com

Top Regulatory News Stories – Week Ending June 15, 2018

Regulatory News Headlines for the week!
#WeKnowRegulatory #RegulatoryAffairs #Pharma
http://ow.ly/uXOE30kw8OL

linkedin.com The FDA granted accelerated approval to Merck’s Keytruda (pembrolizumab) for the treatment of patients with advanced, PD-L1–positive cervical cancer

Happy Fathers Day weekend! #DPDogs

Another great team building event this week - PICTIONARY
#TeamBuilding #EmployeeEngagement

northeastern.edu

Working in Regulatory Affairs: Careers and Trends

Useful info for our followers who aren't actively in #RegulatoryAffairs
#WeKnowRegulatory #NortheasternKnowsRegulatory
http://ow.ly/HrsJ30ku7gC

northeastern.edu Interested in the field of regulatory affairs but not sure where to start? Here’s a guide to help you navigate the industry.

raps.org

A Look at FDA's FY2018 Generic Drug Performance

FDA says it has approved 496 abbreviated new drug applications (ANDAs) and tentatively approved another 114 ANDAs in Fiscal 2018.
#Generics #RegulatoryAffairs

raps.org Eight months into Fiscal 2018, the US Food and Drug Administration (FDA) is on target to approve a similar number of generic drugs as it did the previous year.

linkedin.com

Top Regulatory News Stories – Week Ending June 8, 2018

In case you missed it... Last week's #Regulatory headlines
#WeKnowRegulatory #RegulatoryAffairs

linkedin.com Eli Lilly and Incyte Corporation announced that the FDA has approved OLUMIANT (baricitinib) for the treatment of adults with moderately-to-severely

California Life Science Sector Workforce Trends Report. Can you guess what functions are hardest to fill?
#WeKnowRegulatory #RegulatoryAffairs
http://ow.ly/tl5h30konVX

reuters.com

FDA wants to shorten new drug monopolies to cut costs

“So we’re doing it on the generic side, but we’re also thinking of doing it on the new drug side,” Gottlieb said in an interview on Saturday at ASCO
#drugpricing #ASCO
http://ow.ly/rCqz30kkEuG

reuters.com In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times for rivals to promising new first-to-market medicines.

It's certainly great news that unemployment is so low, but that also means #hiring top talent is more challenging. Especially in #RegulatoryAffairs according to Boston Business Journal, which states:
https://www.bizjournals.com/boston/news/2018/05/16/mass-biotech-sector-s-explosive-growth-poses.html

linkedin.com

Top Regulatory News Stories – Week Ending May 24, 2018

Hey everyone - we'll be out of the office tomorrow, but will do our best to respond to emails/calls/texts. Have a good MDW!

#RegulatoryAffairs #MemorialDayWeekend

linkedin.com Hi folks, I am publishing my blog a day early due to the holiday weekend. Here are the top regulatory stories for this week: On Monday Dova

endpts.com

FDA chief Gottlieb is building a regulatory speedway to accelerate gene therapy development

The gene therapy optimism is promising. Inspiring to see the FDA support innovative pathways like this.
#RegulatoryAffairs #GeneTherapy
http://ow.ly/6NPb30k8PlP

endpts.com In a rallying cry for gene therapy, FDA Commissioner Scott Gottlieb says he's determined to clear the pathway for drug developers in a move to accelerate the first wave of gene therapies pointed to the market. The first therapeutic area to benefit from new surrogate endpoints will be hemophilia, Got...

Big THANK YOU to our Office Manager Veronica Ritchie for an exciting game of Dennis Partners themed Family Feud!
#Recruiting #RegulatoryAffairs

washingtonpost.com

Analysis | The Health 202: Here's what to expect from Trump's speech on drug prices

Only a few more hours. What do you think we'll hear?
#DrugPricing #Pharma
http://ow.ly/h9S030jWZLw

washingtonpost.com Hint: it's not what Democrats are hoping for.

statnews.com

Trump often ad libs. What does that mean for his drug pricing speech?

What do you think will come of this?
#DrugPricing #RegulatoryAffairs
https://www.statnews.com/2018/05/07/trump-drug-pricing-speech-policy/

statnews.com President Trump is set to deliver a major address on drug prices this week. And perhaps more than with any other president, Washington is wondering: What will he say?

Would you look at this little Buster! Happy Friday from our newest visitor!

#DPdogs

linkedin.com

5 Simple Ways to Show Appreciation

Which one is most important for you as a leader or an employee?

linkedin.com What's your reaction when you hear a 5-time Super Bowl winning quarterback state he feels everyone could be more appreciated? Part of it depends on

Are you done working yet?
#DPDogs

Leo Cain of Dennis Partners

Our newest recruiter, Leo, has made impressive progress in the past year.
#WeKnowRegulatory #HeKnowsRegulatory #RegulatoryAffairs
https://youtu.be/hsJ_NHrd7ac

healthexec.com

White House indefinitely postpones Trump's speech on lowering drug prices

Update - White House indefinitely postpones Trump's speech on lowering drug prices.
#pharma #drugpricing
http://ow.ly/Fysj30jF1He

healthexec.com President Donald Trump has postponed this week’s speech on battling rising prescription drug costs, according to the White House. No future date, time or location has been announced for the speech, previously scheduled for Thursday, April 26.

Two of our more senior canine staffers - sometimes they need to do a bit of one on one #conflictresolution and sometimes they suck up to the boss 😏
#DPdogs

linkedin.com

The Value of Interview Preparation

Fail to Plan - Plan to Fail
#JobInterview #RegulatoryAffairs #preparation
http://ow.ly/VbeO30jwdbu

linkedin.com In the process of planning your next Strategic Career Move, the value of Interview Preparation can never be taken lightly. Too often I find myself

linkedin.com

Top Regulatory News Stories – Week Ending April 13, 2018

ICYMI: Regulatory News Headlines from last week!
#WeKnowRegulatory #RegulatoryAffairs
http://ow.ly/P0YJ30jvWSJ

linkedin.com This was a relatively busy week with new draft guidances, new orphan drug designations, two supplemental approvals, and the lifting of a clinical

reddit.com

I'm Leah Christl—Director of the Therapeutic Biologics and Biosimilars Staff at FDA’s Center for Drug Evaluation and Research. Let's talk about biosimilars. AMA! • r/pharmacy

Super informative AMA from Leah Christl from the FDA on #Biosimilars
https://www.reddit.com/r/pharmacy/comments/8ac3l4/im_leah_christldirector_of_the_therapeutic/
#FDA #RegulatoryAffairs #RedditAMA

reddit.com Hello reddit! I’m Leah Christl, and I am the Director of the Therapeutic Biologics and Biosimilars Staff at the Center for Drug Evaluation and...

"Regulatory Trivia for 800, Alex!"

Great team-building Jeopardy covering internal and industry topics yesterday 🙌

#WeKnowRegulatory #RegulatoryAffairs

www.dennispartners.com

What is a personal brand? What have you done to cultivate it? | Dennis Partners

If you're reading this post, you should read this blog.
#digitalbrand #reputation #RegulatoryAffairs
http://www.dennispartners.com/candidate-newsletter/personal-brand-done-cultivate/

www.dennispartners.com Most of us associate the term “brand” with companies or sports figures which market their products or personas. The billions of dollars that are invested each year into building and maintaining these brands demonstrates the importance of branding. As an individual, you have a brand as well. Ther...

bloomberg.com

Trump Tariffs Target Key Ingredients for Dozens of Drugs

How will this impact our industry?
#pharma #tariffs
http://ow.ly/1QVm30jjnQQ

bloomberg.com The Trump administration’s proposed tariffs on thousands of Chinese-manufactured products would target dozens of key products used by drugmakers, as well as medical devices including pacemakers and artificial joints.

Employee edition of #TransformationTuesday

Thanks Leo for being a good sport 👍👍

If you haven't figured it out yet, we love our dogs! Here's today's Friday work crew
#DPDogs

[03/30/18]   #RegulatoryAffairs News Highlights for the week!
#WeKnowRegulatory
https://www.linkedin.com/pulse/top-regulatory-news-stories-week-ending-march-30-2018-jack-vendetti/?published=t

mmm-online.com

Understanding FDA's Blueprint for Transparency

This week the FDA officially launched its pilot project to publicly release portions of clinical trial-related summaries from pivotal trials
#FDA #transparency
http://ow.ly/uGoe30jboOK

mmm-online.com The Food and Drug Administration regulates more than a third of the U.S. economy. And its new commissioner, Scott Gottlieb, is trying to shake up how it does so.

Want your business to be the top-listed Health & Beauty Business in Yarmouth Port?

Click here to claim your Sponsored Listing.

Videos (show all)

Telephone

Address


125 Route 6A
Yarmouth Port, MA
02675

General information

Our firm assists both the client company and the business professional, saving both parties time by managing almost every aspect of the hiring process. We work closely with the client company to identify not only the key job requirements but also the company's personality. We match the values of our candidates with the company's culture through our comprehensive interviewing and screening process in order to present only the most highly qualified and suitable candidates. We pride ourselves on building relationships and gaining the trust of passive candidates. Our goal at Dennis Partners is to become the premier Regulatory Affairs recruiting specialist for both our clients and our candidates. We are proactive in our approach by having the right people, methodologies, technologies, and business ethics in place to answer your critical Regulatory Affairs staffing needs. We work in the following Regulatory areas: Specialties: • Advertising/Promotion • CMC • Global/International • Labeling • Operations • Submission • General Therapeutic Area: • Oncology • Pain/Inflammation/Autoimmune • CNS • Infectious Disease OUR SERVICES To reduce the inefficiency of working with multiple recruiters, we offer a portfolio of hiring tools to answer a wide range of needs and to establish reliable partnerships with our clients: • Applicant Tracking System • Candidate Sourcing • CV Screening and Short List Creation • Compensation Surveys and Industry Intelligence • Relocation Services • Financial advisors that specifically deal with career transitions

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00
Other Yarmouth Port health & beauty businesses (show all)
Reliable In Home Healthcare Reliable In Home Healthcare
PO Box 293
Yarmouth Port, 02675

An independent provider of comprehensive, professional in-home senior care.

Cape Cod Home Helpers Cape Cod Home Helpers
411 Route 6A
Yarmouth Port, 02675

Cape Cod Home Helpers specializes in providing the best in home health care solutions for seniors and those recuperating from recent illness or injury.

Cape Cod Healthy Connections Cape Cod Healthy Connections
92 Homers Dock Rd
Yarmouth Port, 02675

Our mission is to improve the health and well-being of all those in our community.